Search Within

Cristina R Antonescu

  1. "Ciara Kelly"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (15)
Groups
  1. Department of Medicine (31)
  2. Department of Pathology and Laboratory Medicine (31)
  3. GSK Faculty (31)
  4. Sarcoma Service (31)
  5. Solid Tumor Oncology Division (31)
  6. Tow Center for Developmental Oncology (TCDO) (31)

More Groups

People
  1. Ciara Kelly (31)
  2. Sandra D'Angelo (30)
  3. Ping Chi (29)
  4. William Tap (29)
  5. Mark Dickson (28)
  6. Mary Keohan (28)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (5)
  4. 2022 (6)
  5. 2021 (1)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Clinical Cancer Research (6)
  3. Annals of Oncology (3)
  4. Journal for ImmunoTherapy of Cancer (2)
  5. Nature Communications (2)
  6. Annals of Surgical Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. American Association for Cancer Research (6)
  3. Oxford University Press (4)
  4. Biomed Central Ltd (2)
  5. Nature Publishing Group (2)
  6. Springer (2)

More Publishers

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
    Journal Article

    Nacev, B. A.; Bradic, M.; Woo, H. J.; Richards, A. L.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Chi, P.; Movva, S.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma
    Journal Article

    Rosenbaum, E.; Seier, K.; Bradic, M.; Movva, S.; Kelly, C. M.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Nacev, B. A.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas
    Meeting Abstract

    Rosenbaum, E.; Ehrich, F.; Bradic, M.; Kelly, C. M.; Movva, S.; Chan, J.; Chi, P.; Banks, L.; Dickson, M.; Keohan, M. L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Do patients with myxofibrosarcoma and undifferentiated pleomorphic sarcoma have different clinical outcomes to immune checkpoint blockade-based therapy?
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Bradic, M.; Desir, R.; Kelly, C. M.; Movva, S.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-Mérida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Novel genomic risk stratification model for primary gastrointestinal stromal tumors (GIST) in the adjuvant therapy era
    Journal Article

    Dermawan, J. K.; Kelly, C.; Gao, Z.; Smith, S.; Jadeja, B.; Singer, S.; Tap, W. D.; Chi, P.; Antonescu, C. R.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of regional melphalan via limb infusion and systemic PD1 blockade in patients with extremity sarcoma
    Meeting Abstract

    Bartlett, E. K.; D'Angelo, S.; Kelly, C.; Rosenbaum, E.; Movva, S.; Erinjeri, J.; Fisher, C.; Singer, S.; Antonescu, C.; Ariyan, C.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save